Scientist (maternity leave temp), cell-based immunotherapies
Are you enthusiastic about developing next generation cell-based immunotherapies that bring new hope to late-stage cancer patients? Are you experienced in immunology and have a special interest in the field of immune oncology and cell-based immunotherapies? Do you thrive in a passionate and informal working environment where you will work closely with our team to reach our goals? Then you could be our new highly valued Scientist (maternity leave temp) in our R&D team at Cbio A/S.
About the position
Today, Tumor Infiltrating Lymphocyte (TIL) therapy is the most promising cell-therapy for cancer patients with solid tumors where all other therapeutic interventions have been exhausted. TIL therapy is known to be safe and well tolerated and has shown remarkable clinical results with overall response rates of up to 50 % and complete remission in up to 20 % in several cancer indications in a heavily pre-treated patient population.
At Cbio, we have developed a TIL product with transformative potential, novoleucel, that is now ready for clinical development. In our R&D team, we are further characterizing this new TIL product regarding tumor killing capacity, T-cell repertoire, phenotype, etc. You will also be working closely together with the production team transferring assays and protocols from R&D to manufacturing and with the clinical site supporting the regulatory approval and afterwards the clinical trial. Furthermore, we are collaborating with various academic and industrial partners to further advance cell-based therapies.
As our new Scientist (temp), you will help the R&D team in a 6-months temporary position as one of our coworkers is on maternity leave, and will help the team with a possibility for further extension.
Qualifications
We are looking for a person experienced in immune oncology or related area with documented practical experience in cell culture and flow cytometry. You have a scientific degree (MSc/PhD), and have a good understanding of cancer, immunology, and/or cell-based therapies.
As a person you are self-going, curious, and flexible. You are committed and collaborate well with people with various backgrounds and skills at all levels. Furthermore, you have a positive attitude and can stay on top of things in a dynamic working environment.
Working at Cbio
- Gives you the opportunity to join us in the fight against cancer by enabling cancer cure. TIL therapy will become one of the first approved cell-based therapies for solid tumors – with novoleucel you can help expand the reach to more cancer patients worldwide
- Offers you the possibility to make an impact and where your dedication, contributions and opinions are highly valued
Application and contact
Submit your application via the button “Apply”.
For further information, please contact founder, CEO Ulrik Cordes at +45 31 62 53 33. Applications will be reviewed continuously, and interviews planned as soon as suitable candidates are identified.
Cbio – enabling cancer cure
Cbio A/S is a clinical stage cell therapy company started in 2019 focusing on Tumor Infiltrating Lymphocyte (TIL) therapy – the most promising cell therapy for solid tumors. We have licensed a clinically proven TIL product ‘novoleucel’ from world-leading academic institution, Herlev Hospital in Denmark and have developed a proprietary minimally invasive, high potent TIL product with transformative potential. Our lead TIL therapy product, novoleucel, is soon ready for clinical validation.
We are located in Søborg (Copenhagen area), Denmark, in a 1,000 m2 state-of-the-art facility where we develop and produce cell-based therapy products for clinical use.
Apply with QuickApply on Jobindex.
